Review
doi: 10.1023/a:1022190820131.
Nitric oxide and cardiovascular protection
Affiliations
- PMID: 12652157
- DOI: 10.1023/a:1022190820131
Item in Clipboard
Review
Nitric oxide and cardiovascular protection
Heart Fail Rev.
2003 Jan.
Abstract
Nitric oxide (NO) plays a critical role in ischemic heart disease and ischemia-reperfusion. There is an increasing body of evidence to support the role of NO in myocardial and vascular protection in disease. The finding that NO might act as a trigger of late ischemic preconditioning (IPC) might lead to the development of novel anti-ischemic therapy. The role of NO signaling in the cardioprotective effects of ACE inhibitors and angiotensin II type 1 receptor(AT(1)) receptor antagonists is an active area of study.
Similar articles
-
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.Ann Thorac Surg. 1995 Sep;60(3):789-92. doi: 10.1016/0003-4975(95)00192-N. Ann Thorac Surg. 1995. PMID: 7545893
-
Preconditioning for cardioprotection against ischemia reperfusion injury: the roles of nitric oxide, reactive oxygen species, heat shock proteins, reactive hyperemia and antioxidants--a mini review.Can J Cardiol. 2001 Oct;17(10):1075-82. Can J Cardiol. 2001. PMID: 11694897 Review.
-
Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research.J Mol Cell Cardiol. 2001 Nov;33(11):1897-918. doi: 10.1006/jmcc.2001.1462. J Mol Cell Cardiol. 2001. PMID: 11708836 Review.
-
Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.Hypertens Res. 2001 Jul;24(4):403-9. doi: 10.1291/hypres.24.403. Hypertens Res. 2001. PMID: 11510753
-
Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.Hypertension. 1997 Dec;30(6):1621-7. doi: 10.1161/01.hyp.30.6.1621. Hypertension. 1997. PMID: 9403592
Cited by
-
Emergent role of gasotransmitters in ischemia-reperfusion injury.Med Gas Res. 2011 Apr 27;1(1):3. doi: 10.1186/2045-9912-1-3. Med Gas Res. 2011. PMID: 22146243 Free PMC article.
-
Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz).PLoS One. 2015 Mar 25;10(3):e0121069. doi: 10.1371/journal.pone.0121069. eCollection 2015. PLoS One. 2015. PMID: 25807532 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous